Identification of 5-Iodotubercidin as a genotoxic drug with anti-cancer potential.

PLoS One 2013 7;8(5):e62527. Epub 2013 May 7.

Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University, Shanghai, China.

Tumor suppressor p53, which is activated by various stress and oncogene activation, is a target for anti-cancer drug development. In this study, by screening panels of protein kinase inhibitors and protein phosphatase inhibitors, we identified 5-Iodotubercidin as a strong p53 activator. 5-Iodotubercidin is purine derivative and is used as an inhibitor for various kinases including adenosine kinase. We found that 5-Iodotubercidin could cause DNA damage, verified by induction of DNA breaks and nuclear foci positive for γH2AX and TopBP1, activation of Atm and Chk2, and S15 phosphorylation and up-regulation of p53. As such, 5-Iodotubercidin induces G2 cell cycle arrest in a p53-dependent manner. Itu also induces cell death in p53-dependent and -independent manners. DNA breaks were likely generated by incorporation of 5-Iodotubercidin metabolite into DNA. Moreover, 5-Iodotubercidin showed anti-tumor activity as it could reduce the tumor size in carcinoma xenograft mouse models in p53-dependent and -independent manners. These findings reveal 5-Iodotubercidin as a novel genotoxic drug that has chemotherapeutic potential.

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0062527PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3646850PMC
December 2013
17 Reads

Publication Analysis

Top Keywords

dna breaks
8
-independent manners
8
p53-dependent -independent
8
induces cell
8
genotoxic drug
8
5-iodotubercidin
7
phosphorylation up-regulation
4
up-regulation p53
4
s15 phosphorylation
4
chk2 s15
4
atm chk2
4
p53 5-iodotubercidin
4
adenosine kinase
4
cell cycle
4
cycle arrest
4
kinases including
4
5-iodotubercidin induces
4
including adenosine
4
activation atm
4
topbp1 activation
4

References

(Supplied by CrossRef)
Global cancer statistics
A Jemal et al.
CA Cancer J Clin 2011
Targeting metabolic transformation for cancer therapy
DA Tennant et al.
Nat Rev Cancer 2010
Genomic instability and cancer: an introduction
Z Shen et al.
J Mol Cell Biol 2011
DBC1 phosphorylation by ATM/ATR inhibits SIRT1 deacetylase in response to DNA damage. J Mol Cell Biol
L Zannini et al.
2012

Similar Publications